Radius Health, Inc. (RDUS) News

Radius Health, Inc. (RDUS): $10.48

0.11 (+1.06%)

POWR Rating

Component Grades













Filter RDUS News Items

RDUS News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

RDUS News Highlights

  • RDUS's 30 day story count now stands at 6.
  • Over the past 17 days, the trend for RDUS's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
  • The most mentioned tickers in articles about RDUS are BEAT, DECK and ID.

Latest RDUS News From Around the Web

Below are the latest news stories about Radius Health Inc that investors may wish to consider to help them evaluate RDUS as an investment opportunity.

Radius Health, Inc. 2022 Q4 - Results - Earnings Call Presentation

The following slide deck was published by Radius Health, Inc. in conjunction with their 2022 Q4 earnings call....

SA Transcripts on Seeking Alpha | February 24, 2022

Radius Health (RDUS) Reports Q4 Loss, Tops Revenue Estimates

Radius Health (RDUS) delivered earnings and revenue surprises of 5.71% and 3.30%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 24, 2022

Radius Health, Inc. Fourth Quarter & Full Year 2021 Results

Q4 2021 TYMLOS® net revenue of $65 million vs. $60 million in Q4 2020, up 9%This is a record quarter – over 18 quarters – since the launch in May 2017FY 2021 TYMLOS Net Revenue of $219 vs. $208 million in FY 2020, up 5%Net Loss reduced by ~36%: ($70) million FY 2021 vs ($109) million FY 2020Adjusted EBITDA (Non-GAAP) loss reduced by ~56%: ($24) million FY 2021 vs. ($54) million FY 2020FY 2022 financial objectives: $232 million TYMLOS Net RevenueIncorporate seasonality of Net Revenue: ~42% in 1H

Yahoo | February 24, 2022

Radius Health (RDUS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Radius Health (RDUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | February 17, 2022

Radius Health to Release Fourth Quarter and Full Year 2021 Financial Results, Host Conference Call and Live Webcast on Thursday, February 24, 2022

BOSTON, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Radius Health, Inc. (NASDAQ: RDUS) announced today that it will release its fourth quarter and full year 2021 financial results on Thursday, February 24, 2022. The Company will host a conference call and live audio webcast at 8:30 a.m. ET to discuss the results and provide a company update. Conference Call Information:Domestic Dial-In Number: 1 (866) 323-7965International Dial-In Number: 1 (346) 406-0961Conference ID: 7696052Webcast Link: https://edge.me

Yahoo | February 15, 2022

Market Sentiment Around Loss-Making Radius Health, Inc. (NASDAQ:RDUS)

We feel now is a pretty good time to analyse Radius Health, Inc.'s ( NASDAQ:RDUS ) business as it appears the company...

Yahoo | February 7, 2022

Radius Health sheds 20% of non-sales headcount (NASDAQ:RDUS)

Radius Health <> announced an approximately 20% reduction in its non-sales headcount related to functions that directly or indirectly supported abaloparatide and TYMLOS,

Seeking Alpha | January 13, 2022

Radius Health Completes Business Adjustment

Completion of three pivotal trials in 2021 enables restructuring of the operating infrastructureNon-Sales headcount reduced by approximately 20%Reductions focused on areas that supported abaloparatide clinical and regulatory activitiesCompany to provide Q4 & FY 2021 results and 2022 outlook during earnings on February 24 BOSTON, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (NASDAQ: RDUS), has completed an adjustment of its business. The catalyst for the chang

Yahoo | January 13, 2022

Are Options Traders Betting on a Big Move in Radius Health (RDUS) Stock?

Investors need to pay close attention to Radius Health (RDUS) stock based on the movements in the options market lately.

Yahoo | January 10, 2022

FDA Approves Update On Radius Health''s Tymlos label

The FDA has approved updates to Radius Health Inc''s (NASDAQ: RDUS ) Tymlos label, including removing the boxed warning

Business Insider Markets | December 23, 2021

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.4635 seconds.